NO20032846L - Makrolider - Google Patents

Makrolider

Info

Publication number
NO20032846L
NO20032846L NO20032846A NO20032846A NO20032846L NO 20032846 L NO20032846 L NO 20032846L NO 20032846 A NO20032846 A NO 20032846A NO 20032846 A NO20032846 A NO 20032846A NO 20032846 L NO20032846 L NO 20032846L
Authority
NO
Norway
Prior art keywords
macrolides
Prior art date
Application number
NO20032846A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032846D0 (no
Inventor
Sulejman Alihodzic
Alfonso Pozzan
Daniele Andreotti
Catia Seri
Luca Arista
Luca Tarsi
Stefano Biondi
Silvia Terreni
Francesca Cardullo
Jessica Tibasco
Manuela Ciraco
Frederica Damiani
Sergio Lociuro
Carla Marchioro
Giancarlo Merlo
Anna Mingardi
Daniela Niccolai
Alfredo Paio
Elisabetta Piga
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031309A external-priority patent/GB0031309D0/en
Priority claimed from GB0126276A external-priority patent/GB0126276D0/en
Priority claimed from GB0126277A external-priority patent/GB0126277D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20032846D0 publication Critical patent/NO20032846D0/no
Publication of NO20032846L publication Critical patent/NO20032846L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20032846A 2000-12-21 2003-06-20 Makrolider NO20032846L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0031309A GB0031309D0 (en) 2000-12-21 2000-12-21 Macrolides
GB0126276A GB0126276D0 (en) 2001-11-01 2001-11-01 Macolides
GB0126277A GB0126277D0 (en) 2001-11-01 2001-11-01 Macrolides
PCT/GB2001/005665 WO2002050091A1 (en) 2000-12-21 2001-12-20 Macrolide antibiotics

Publications (2)

Publication Number Publication Date
NO20032846D0 NO20032846D0 (no) 2003-06-20
NO20032846L true NO20032846L (no) 2003-08-20

Family

ID=27256023

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032846A NO20032846L (no) 2000-12-21 2003-06-20 Makrolider

Country Status (20)

Country Link
US (3) US20040077557A1 (cs)
EP (1) EP1363925B8 (cs)
JP (1) JP2004531471A (cs)
KR (1) KR20030068189A (cs)
CN (1) CN1492874A (cs)
AR (1) AR042583A1 (cs)
AT (1) ATE345350T1 (cs)
AU (2) AU1727702A (cs)
BR (1) BR0116431A (cs)
CA (1) CA2432429A1 (cs)
CZ (1) CZ20031751A3 (cs)
DE (1) DE60124594T2 (cs)
ES (1) ES2275621T3 (cs)
HU (1) HUP0302526A2 (cs)
IL (1) IL156561A0 (cs)
MX (1) MXPA03005668A (cs)
NO (1) NO20032846L (cs)
NZ (1) NZ526450A (cs)
PL (1) PL365012A1 (cs)
WO (1) WO2002050091A1 (cs)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2384160T3 (es) 1999-01-13 2012-07-02 Bayer Healthcare Llc Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
SI1478358T1 (sl) 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
HRP20020886A2 (en) * 2002-11-11 2005-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. SUBSTITUTED 9a-N-[N'-(BENZENSULFONYL)CARBAMOYL-γ-AMINOPROPYL) AND 9a-N(N' -(?-CYANOETHIL)-N' -(b
HRP20020991A2 (en) * 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
PL1626714T3 (pl) 2003-05-20 2007-12-31 Bayer Healthcare Llc Diarylowe pochodne mocznika do schorzeń, w których pośredniczy PDGFR
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
ES2297490T3 (es) 2003-07-23 2008-05-01 Bayer Pharmaceuticals Corporation Omega-carboxiarildifenilurea fluoro sustituida para el tratamiento y prevencion de enfermadades y afecciones.
MXPA06001081A (es) * 2003-07-31 2006-04-24 Irm Llc Compuestos biciclicos y composiciones como inhibidores de pdf.
AU2004267044B8 (en) * 2003-08-20 2009-12-17 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon like peptide (GLP)-1 compound or an melanocortin 4 receptor (MC4) agonist peptide
DE602004004156T2 (de) * 2003-08-20 2007-10-11 Eli Lilly And Co., Indianapolis Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagon like peptide (glp)-1-verbindung oder eines am melanocortin-4-rezeptor (mc4) als agonist wirkenden peptids
RU2403237C2 (ru) * 2004-05-14 2010-11-10 Эмисфире Текнолоджис, Инк. Составы и смеси для доставки активных агентов
JP4111994B1 (ja) 2004-12-21 2008-07-02 ファイザー・プロダクツ・インク マクロライド類
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
KR20080103090A (ko) * 2006-03-10 2008-11-26 유조 츠치다 항미생물제 및 항미생물성 조성물
CN103193840A (zh) * 2006-05-01 2013-07-10 大正制药株式会社 大环内酯衍生物
RU2009110254A (ru) 2006-08-24 2010-09-27 Новартис АГ (CH) Производные 2-(пиразин-2-ил)тиазола и 2-(1н-пиразол-3-ил)тиразола и связанные с ним соединения в качестве ингибиторов стеароил-соа десатуразы для лечения метаболических, сердечно-сосудистых и других нарушений
JP2010501541A (ja) * 2006-08-24 2010-01-21 ウォックハート リサーチ センター 抗菌活性を有する新規マクロライド及びケトライド
RU2009114857A (ru) 2006-09-22 2010-10-27 Новартис АГ (CH) Гетероциклические органические соединения
AU2007336238A1 (en) 2006-12-20 2008-06-26 Novartis Ag 2-substituted 5-membered heterocycles as SCD inhibitors
US20110230428A1 (en) * 2008-07-22 2011-09-22 John Wityak Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US20120041194A1 (en) * 2008-08-29 2012-02-16 Triad Multitech Pharmaceuticals, Inc. Nitrogen and sulfur-containing hetrocycle derivatives
WO2010136971A1 (en) * 2009-05-27 2010-12-02 Wockhardt Research Centre Ketolide compounds having antimicrobial activity
JP5722892B2 (ja) 2010-07-15 2015-05-27 武田薬品工業株式会社 複素環化合物
CN102417530A (zh) * 2010-09-26 2012-04-18 中国医学科学院药物研究所 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
AU2011340204B2 (en) * 2010-12-09 2016-04-14 Wockhardt Limited Ketolide compounds
CN103619849B (zh) * 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
HUE034802T2 (en) 2011-08-30 2018-02-28 Chdi Foundation Inc Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2012300246A1 (en) 2011-08-30 2014-03-06 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US8940742B2 (en) * 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EA201690713A1 (ru) 2013-10-04 2016-08-31 Инфинити Фармасьютикалз, Инк. Гетероциклические соединения и их применения
PT3119397T (pt) 2014-03-19 2022-04-11 Infinity Pharmaceuticals Inc Compostos heterocíclicos para utilização no tratamento de distúrbios mediados por pi3k-gama
CA2955379C (en) 2014-07-17 2022-12-13 Chdi Foundation, Inc. Methods and compositions for treating hiv-related disorders
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
KR20160061743A (ko) 2014-11-24 2016-06-01 주식회사 엘지화학 고흡수성 수지 및 이의 제조 방법
MX390633B (es) 2015-09-14 2025-03-04 Infinity Pharmaceuticals Inc Formas solidas de derivados de isoquinolinona, proceso de fabricacion, composiciones que las contienen y metodos de uso de las mismas.
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN110272417B (zh) * 2019-06-18 2021-07-13 五邑大学 2-甲基-1,8-萘啶类化合物及其制备方法与应用
KR20220113431A (ko) 2019-12-02 2022-08-12 스톰 테라퓨틱스 리미티드 Mettl3 저해제로서의 폴리헤테로환식 화합물
US11999703B1 (en) 2023-10-25 2024-06-04 King Faisal University 5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ZA989835B (en) * 1997-10-29 1999-05-05 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
WO1999021870A1 (en) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
CA2359708C (en) * 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
WO2002016380A1 (en) * 2000-08-22 2002-02-28 Basilea Pharmaceutica Ag New macrolides with antibacterial activity
CN1589277A (zh) * 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂

Also Published As

Publication number Publication date
EP1363925B8 (en) 2007-04-25
NZ526450A (en) 2005-04-29
CN1492874A (zh) 2004-04-28
ATE345350T1 (de) 2006-12-15
HUP0302526A2 (hu) 2003-11-28
CA2432429A1 (en) 2002-06-27
AU1727702A (en) 2002-07-01
MXPA03005668A (es) 2004-12-03
NO20032846D0 (no) 2003-06-20
PL365012A1 (en) 2004-12-27
CZ20031751A3 (cs) 2004-03-17
DE60124594D1 (de) 2006-12-28
AR042583A1 (es) 2005-06-29
AU2002217277B2 (en) 2005-06-16
US20040077557A1 (en) 2004-04-22
ES2275621T3 (es) 2007-06-16
US20060211636A1 (en) 2006-09-21
KR20030068189A (ko) 2003-08-19
JP2004531471A (ja) 2004-10-14
EP1363925B1 (en) 2006-11-15
DE60124594T2 (de) 2007-10-04
IL156561A0 (en) 2004-01-04
US20050215495A1 (en) 2005-09-29
EP1363925A1 (en) 2003-11-26
WO2002050091A1 (en) 2002-06-27
BR0116431A (pt) 2004-06-22

Similar Documents

Publication Publication Date Title
NO20032846L (no) Makrolider
ATE252099T1 (de) Biarylcarboxamide
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATA2932001A (de) Schneefräse
DE50102988D1 (de) Bodenwischer
DE50100710D1 (de) Wischblatt
ATE262530T1 (de) Indolochinazolinone
DE50104651D1 (de) Fahrzeugfaltverdeck
PT1268453E (pt) Metabolitos de agonista/antagonista de estrogenio
DE10192638T1 (de) Bohrstangenladevorrichtung
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de) Sulfonylguanidine
DE10196064T1 (de) Halbleiterfotodektionsgerät
DE50100817D1 (de) Kugelgelenk
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
PT1317179E (pt) Formulacoes de mesotriona
ATE476423T1 (de) Benzoylpyridazine
DE50007634D1 (de) Kardioplegieballonkatheter
DE10195909T1 (de) Viehfüttervorrichtung
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE10195992T1 (de) Oberflächenendbearbeitungsbelag
NO20023353D0 (no) Geofonkobling
ATE284887T1 (de) Thienopyrrolidinone

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application